Table 2 Radiotherapy as first-line... | American Society of Hematology

Table 2

Radiotherapy as first-line treatment in patients with OAML

Reference, year	No. of patients	Stage I, %	Gy (mean)	CR, %	LR, %	DR, %	Survival, %	LRM, %
Le et al,⁶⁷ 2002	31	100	30-40 (34)	100	0	16	10-y PFS 71, OS 73	3
Fung et al,⁵ 2003	48	81	30.6	100	8	25	10-y OS 81, DSS 100	0
Hasegawa et al,⁴⁶ 2003	20	95	30	100	5	20	10-y PFS 70, DSS 100	0
Tsang et al,⁶⁸ 2003	30	97	25	97	17	10	5-y DFS 74, OS 97	ND
Uno et al,⁴⁷ 2003	50	100	20-46 (36)	98	6	6	5-y OS 91	2
Lee et al,⁴⁸ 2005	29	100	30-45 (30)	100	3	0	3-y EFS 93, OS 100	0
Ejima et al,⁵¹ 2006	42	100	30-36	84	10	10	5-y PFS 77, DSS 100	0
Suh et al,⁵² 2006	48	96	30.6	96	6	0	10-y DFS, 93 DSS 98	2
Tanimoto et al,⁵⁴ 2007	58	94	30-40	83	9	2	10-y PFS 72, OS 92	0

Reference, year	No. of patients	Stage I, %	Gy (mean)	CR, %	LR, %	DR, %	Survival, %	LRM, %
Le et al,⁶⁷ 2002	31	100	30-40 (34)	100	0	16	10-y PFS 71, OS 73	3
Fung et al,⁵ 2003	48	81	30.6	100	8	25	10-y OS 81, DSS 100	0
Hasegawa et al,⁴⁶ 2003	20	95	30	100	5	20	10-y PFS 70, DSS 100	0
Tsang et al,⁶⁸ 2003	30	97	25	97	17	10	5-y DFS 74, OS 97	ND
Uno et al,⁴⁷ 2003	50	100	20-46 (36)	98	6	6	5-y OS 91	2
Lee et al,⁴⁸ 2005	29	100	30-45 (30)	100	3	0	3-y EFS 93, OS 100	0
Ejima et al,⁵¹ 2006	42	100	30-36	84	10	10	5-y PFS 77, DSS 100	0
Suh et al,⁵² 2006	48	96	30.6	96	6	0	10-y DFS, 93 DSS 98	2
Tanimoto et al,⁵⁴ 2007	58	94	30-40	83	9	2	10-y PFS 72, OS 92	0

CR indicates complete remission rate; LR, local recurrence rate; DR, distal recurrence rate; LRM, lymphoma-related mortality; PFS, progression-free survival rate; OS, overall survival rate; DSS, disease-specific survival rate; DFS, disease-free survival rate; EFS, event-free survival rate; and ND, not determined.

View Large

This Feature Is Available To Subscribers Only